Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 28, 2023

BUY
$0.29 - $0.64 $6,556 - $14,468
22,607 Added 35.78%
85,783 $26,000
Q4 2022

Feb 02, 2023

SELL
$0.38 - $22.5 $14,124 - $836,302
-37,169 Reduced 37.04%
63,176 $25,000
Q3 2022

Oct 31, 2022

BUY
$0.73 - $23.4 $16,960 - $543,675
23,234 Added 30.13%
100,345 $71,000
Q2 2022

Jul 29, 2022

BUY
$0.66 - $1.81 $24,369 - $66,830
36,923 Added 91.88%
77,111 $62,000
Q1 2022

Apr 29, 2022

BUY
$1.27 - $2.47 $6,214 - $12,085
4,893 Added 13.86%
40,188 $67,000
Q4 2021

Feb 07, 2022

SELL
$2.21 - $3.22 $90,168 - $131,376
-40,800 Reduced 53.62%
35,295 $83,000
Q3 2021

Nov 01, 2021

BUY
$2.8 - $3.72 $178,130 - $236,658
63,618 Added 509.88%
76,095 $237,000
Q2 2021

Aug 12, 2021

SELL
$2.61 - $4.17 $50,252 - $80,289
-19,254 Reduced 60.68%
12,477 $42,000
Q1 2021

May 13, 2021

BUY
$2.91 - $4.32 $25,139 - $37,320
8,639 Added 37.41%
31,731 $99,000
Q4 2020

Feb 04, 2021

SELL
$2.15 - $3.5 $442,874 - $720,958
-205,988 Reduced 89.92%
23,092 $64,000
Q3 2020

Nov 09, 2020

BUY
$2.77 - $6.17 $374,966 - $835,214
135,367 Added 144.45%
229,080 $655,000
Q2 2020

Jul 20, 2020

BUY
$0.87 - $3.13 $33,594 - $120,861
38,614 Added 70.08%
93,713 $291,000
Q1 2020

Apr 30, 2020

BUY
$0.73 - $1.91 $30,067 - $78,670
41,189 Added 296.11%
55,099 $52,000
Q4 2019

Jan 28, 2020

SELL
$0.48 - $1.38 $9,341 - $26,857
-19,462 Reduced 58.32%
13,910 $19,000
Q3 2019

Nov 04, 2019

BUY
$0.47 - $1.05 $15,684 - $35,040
33,372 New
33,372 $16,000

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.